Position
Fidelity in Vera Therapeutics, Inc.
Back to the book · All holders of VERA
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $7.17M$40.23 → $42.91
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 2.89M | $146.1M | — | — | — | 0.0% |
| Q1 2026 | 2.68M | $107.7M | $40.23 | −$27.9M | −$10.6M | 0.0% |
| Q2 2026 | 2.77M | $119M | $42.91 | $7.17M | $4.19M | 0.0% |